The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com
ChartZero

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sun., Apr. 26, 2:15 AM

Slide #2. Innocoll AG Secondary Offering

Company: Innocoll AG (NASDAQ:INNL)
Date announced: 4/24/2015
Shares Offered: 3,321,669
Date of Pricing: 4/24/2015
Price Per Share: $9.00
Secondary Offering Details: Innocoll AG (Nasdaq:INNL), a specialty pharmaceutical company, today announced the pricing of its follow-on public offering of 3,321,669 American Depositary Shares ("ADSs") at a public offering price of $9.00 per ADS. Of the ADSs in the offering, 1,999,690 ADSs are being offered by the Company and 1,321,979 ADSs are being offered by selling shareholders. The Company will not receive any proceeds from the sale of ADSs by the selling shareholders. The offering is expected to close on April 30, 2015, subject to the satisfaction of customary closing conditions.

Innocoll is a global, commercial stage, specialty pharmaceutical company, with late stage development programs targeting areas of significant unmet medical need. Co.'s product candidates are XaraColl® for the treatment of post-operative pain and Cogenzia® for the treatment of diabetic foot infections. CollaGUARD, for prevention of post-surgical adhesions, has been approved in 45 countries in Europe, Asia and emerging markets. Co. utilizes its proprietary collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates. Co. manufactures its products in its own commercial scale facility.
Open the INNL Page at The Online Investor »

Company Name:  Innocoll AG
Website:  www.innocollinc.com
Sector:  Drugs & Pharmaceuticals
 

Open the INNL Page at The Online Investor (in a new window) »

April 26, 2015    2:15 AM Eastern
Quotes delayed 20 minutes


Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.